Skip to main content

Dɛn dɔn gi yu di Obinutuzumab injɛkshɔn? Lɛ wi tɔk bɔt dis mɛrɛsin insay simpul wɔd dɛn (Obinutuzumab injection) .

Dɛn dɔn gi yu di Obinutuzumab injɛkshɔn? Lɛ wi tɔk bɔt dis mɛrɛsin insay simpul wɔd dɛn (Obinutuzumab injection) .

Yu ɔ pɔsin we yu sabi go dɔn fil smɔl fred ɛn fred we yu dɔktɔ tɛl yu fɔ bigin tek Obinutuzumab. Yu kin gɛt bɔku kwɛstyɔn dɛn lɛk, ‘Wetin na dis mɛrɛsin? Wetin go apin wit dis?’ Dat na rili nɔmal tin. Kansa tritmɛnt na lɔng waka, ɛn fɔ ɔndastand klia wan di mɛrɛsin dɛm wae yu go de tek go ɛp yu bɔrku. So tide, lɛ wi tɔk bɔt dis mɛrɛsin, dis impɔtant pat pan yu tritmɛnt joyn, insay wan rili simpul ɛn padi we.

Mek wi si fos, wetin na Obinutuzumab?

Fɔ tɔk am simpul wan, Obinutuzumab na wan mɛrɛsin we rili advans fɔ fɛt kansa. I de pan wan spɛshal klas ɔf drɔgs we dɛn kɔl `monoclonal antibodies.` Tink bɔt am lɛk sojaman we gɛt bɔku sɛns, we tren. Di wangren tin we i want fɔ du na fɔ fɛn, atak, ɛn pwɛl di kansa sɛl dɛn na wi bɔdi. Dis drɔg gɛt di spɛshal pawa fɔ tɔch ɛn atak di kansa sɛl dɛn nɔmɔ, we de mek di sɛl dɛn we gɛt wɛlbɔdi nɔ pwɛl.

Dɛn kin yuz dis mɛrɛsin mɔ fɔ mɛn tu kayn kansa dɛn we gɛt fɔ du wit blɔd:

1. Chronic Lymphocytic Leukemia (CLL): Dis na kansa we de na di wayt blɔd sɛl dɛn.

2. Fɔlikul Limfoma: Dis na wan kayn kansa we de apin na di limfatik sistɛm. i de pan wan big grup fכ kεnsar dεm we dεn kכl `Non-Hodgkin Lymphoma (NHL).`

Sɔntɛnde yu dɔktɔ kin gi yu dis mɛrɛsin bak fɔ ɔda mɛrɛsin, so if yu gɛt ɛni kwɛstyɔn, nɔ fred fɔ tɔk to yu dɔktɔ bɔt am.

Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu bigin dis mɛrɛsin

Yu sef na di tin we impɔtant pas ɔl. So, i impɔtant fɔ mek yu tɛl yu dɔktɔ bɔt yu kɔmplit wɛlbɔdi istri bifo yu bigin dis tritmɛnt. Mek shɔ se yu tɛl dɛn bɔt ɛni wan pan dɛn tin ya, mɔ if yu gɛt ɛni wan pan dɛn tin ya:

  • Infεkshכn dεm naw: Tεl wi if yu gεt eni infεkshכn naw, lεk fiva, kכf, כ kol. Dis impɔtant mɔ if yu dɔn gɛt di epataytis B vayrɔs trade.
  • Lung ɔr respiratory disease: If yu gɛt prɔblɛm wit yu brith lɛk asma.
  • At sik: If yu bin dɔn gɛt at atak, yu at ritm prɔblɛm, ɔr ɛni ɔda at sik.
  • Di mɛrɛsin dɛn we dɛn kin yuz fɔ mek blɔd nɔ klɔt ɔ fɔ trit: If yu de tek tin dɛn we de mek blɔd tan lɛk Warfarin ɔ Aspirin.
  • Alɛji: If yu gɛt alɛji to dis mɛrɛsin, Obinutuzumab, ɔ ɛni ɔda mɛrɛsin, it, ɔ day.
  • Bɛlɛ: Dis rili impɔtant if yu gɛt bɛlɛ, yu de tray fɔ gɛt bɛlɛ, ɔ yu tink se yu gɛt bɛlɛ .
  • Fɔ gi pikin in bɛlɛ: If yu na mama we de gi pikin in bɛlɛ, yu fɔ rili tɔk bɔt dat bak.

Aw a go gi yu dis mɛrɛsin?

Dɛn kin gi dis mɛrɛsin as infushɔn insay wan vein. Dis nɔto sɔntin we yu go ebul fɔ du na os. Dɛn kin gi yu na ɔspitul ɔ klinik, ɔnda di sɔpɔtishɔn fɔ di dɔktɔ dɛn we tren . Di fɔs tɛm we dɛn gi yu di mɛrɛsin, dɛn go gi yu am smɔl smɔl. Dis na fɔ si aw yu bɔdi de ansa di mɛrɛsin. If ɔltin go fayn, yu kin gi am kwik kwik wan di nɛks tɛm.

Impɔtant: Dɛn dɔn gi yu dis mɛrɛsin fɔ yu nɔmɔ. Nɔ sheb am wit ɛni ɔda pɔsin fɔ ɛni rizin.

Wetin a go du if a mis wan doz fɔ tek mɛrɛsin?

I rili impɔtant fɔ kip di de dɛn we dɛn dɔn sɛtul fɔ dis tritmɛnt. If yu nɔ ebul fɔ go na ɔspitul di de we dɛn dɔn plan fɔ go, kɔl yu dɔktɔ ɔ klinik wantɛm wantɛm ɛn mek dɛn no. Dɛn go tɛl yu wetin fɔ du nɛks.

Wetin fɔ du if di mɛrɛsin go ɔp?

Bikɔs dɛn kin gi dis na ɔspitul, di chans fɔ mek dɛn tek am pasmak kin rili smɔl. Bɔt if yu tink se sɔntin lɛk dis kin apin, tɛl di dɔktɔ dɛn wantɛm wantɛm. Ɔda we de fɔ kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta na di Kɔlɔmbɔ Nashɔnal Ospital , ɔ go na di Imejɛnsi Tritmɛnt Yunit (ETU) na di ɔspitul we de nia yu.

Tin dɛm wae yu fɔ no bɔt wae yu de trit yu

I rili impɔtant fɔ pe atɛnshɔn to di chenj dɛn we de apin na yu bɔdi we yu de tek dis mɛrɛsin.

  • Riakshɔn afta di fɔs doz: We yu fɔs tek di mɛrɛsin, sɔm pipul dɛn kin gɛt fiva, kol, diziz, ɛn smɔl chenj na dɛn brith. Dɛn tin ya na nɔmal tin. Bɔt if yu gɛt ɛni wan pan dɛn tin ya, tɛl di nɔs ɔ dɔktɔ wantɛm wantɛm.
  • Protɛkt yusɛf frɔm infɛkshɔn: Dis mɛrɛsin kin mek yu bɔdi nɔ ebul fɔ fɛt sik (immunity). So, yu kin gɛt infɛkshɔn mɔ. Stay away frɔm pipul dɛm wae gɛt kol ɛn flu as mɔr as yu ebul. If yu gɛt sɔm sayn dɛn lɛk fiva, bɔdi we de at, trot we de at, ɛn kɔf, nɔ fɔ tek mɛrɛsin fɔ yusɛf ɛn kɔl yu dɔktɔ wantɛm wantɛm.
  • Risk fɔ blɔd: Dis mɛrɛsin kin mek yu blɔd ɔ brus smɔl smɔl. Tɛl yu dɔktɔ if yu gɛt ɛni ɔdinari brus, blɔd we de kɔmɔt na yu gɔm we yu de brus yu tit, ɔ ɛni ɔda blɔd we nɔ kɔmɔn.
  • Bεlε εn bεlε (i rili imכtant): Nɔ bεlε we yu de tek dis mεdisin εn fכ 6 mכnt afta yu stכp di tritmεnt. Dis mɛrɛsin kin ambɔg di pikin we nɔ bɔn yet bad bad wan. So, tɔk to yu dɔktɔ bɔt di bɛst we fɔ kɔntrol di pikin. Bak,Nɔ gi yu pikin in bɛlɛ we yu de trit am ɛn fɔ 6 mɔnt afta yu dɔn stɔp.

Wetin na di sayd ɛfɛkt dɛn we di mɛrɛsin kin gɛt?

Lɛk ɛni mɛrɛsin, Obinutuzumab kin mek yu gɛt sayd ɛfɛkt. Bɔt, nɔto ɔlman kin gɛt dɛn. Di tebul we de dɔŋ ya de sho klia wan bɔt dɛn tin ya.

Nature of di sayd ɛfɛkt Diskripshɔn ɛn di simptom dɛm
Sayd ɛfɛkt dɛn we yu fɔ ripɔt to yu dɔktɔ wantɛm wantɛm
Alɛji we pɔsin kin gɛt Skin rash, it, swel na di lip ɔ fes.
I nɔ izi fɔ blo I nɔ izi fɔ blo, di chɛst tayt ɔ pen.
Di sayn dɛn we de sho se di blɔd sɛl dɛn nɔ bɔku Dis mɛrɛsin kin mek di wayt blɔd sɛl dɛn, di rɛd blɔd sɛl dɛn, ɛn di pletlɛt dɛn nɔ bɔku. Dis kin mek di risk fɔ gɛt infɛkshɔn (fiva, kɔf), blɔd (bruiz, blak stɔl).
Di sayn dɛm we de sho se di liva dɔn pwɛl Dak yɔlɔ/brawn urine, yu yay ɔ skin de yɔlɔ, pen na di ɔp rayt pat na di bɛlɛ, taya pasmak, nɔs.
Simptom dɛm wae gɛt fɔ du wit di nervɔs sistɛm I nɔ kin tɔk fayn, i nɔ kin izi fɔ ɔndastand, i nɔ kin izi fɔ waka, i nɔ kin balans, i kin vɔmit, i kin gɛt siriɔs diziz.
Sayd ɛfɛkt dɛn we nɔ kin nid fɔ go to dɔktɔ (bɔt dɛn fɔ ripɔt to dɔktɔ if dɛn kɔntinyu fɔ du am) .
Ɔda smɔl smɔl sik dɛn Kɔnstipɛshɔn, jɔyn pen, mɔsul pen.

Dis list nɔ de inklud ɔl di sayd ɛfɛkt dɛn we pɔsin kin gɛt. If yu notis ɛni ɔda tin we difrɛn ɔ we nɔ kɔmɔn, duya tɛl yu dɔktɔ.

Mɛsej we dɛn kin kɛr go na os

  • Obinutuzumab na wan advans drɔg we de tɔch ɛn pwɛl kansa sɛl dɛn. Dis na impɔtant pat pan yu tritmɛnt joyn.
  • Bifo yu bigin fɔ trit yu, tɛl yu dɔktɔ bɔt ɔl yu wɛlbɔdi prɔblɛm ɛn di mɛrɛsin dɛn we yu de tek.
  • Protɛkt yusɛf frɔm infɛkshɔn we yu de du tritmɛnt. If yu gɛt sɔm sayn dɛn lɛk fiva ɛn kɔf, go to dɔktɔ wantɛm wantɛm.
  • I rili impɔtant: Nɔ gɛt bɛlɛ ɔltogɛda we yu de trit yu ɛn fɔ 6 mɔnt afta yu dɔn stɔp.
  • Nɔ skip di apɔntinmɛnt dɛn we yu dɔn plan fɔ tek fɔ tek mɛrɛsin. If yu gɛt ɛni prɔblɛm, tɛl di ɔspitul bifo tɛm.
  • Tɛl yu dɔktɔ wantɛm wantɛm bɔt ɛni chenj we nɔ kɔmɔn na yu bɔdi, mɔ di sayn dɛn we de sho se yu gɛt siriɔs sayd ɛfɛkt. Nɔ fred ɔ sɔfa yu wan. Di mɛdikal tim de ya fɔ ɛp yu.

obinutuzumab, gazyva, kansa tritmɛnt, monoklɔnal antibodi, kronik limfosaytik lukimiya, fɔlikul limfoma, kansa mɛrɛsin
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 2 + 7 =
Dɛn dɔn gi yu di Obinutuzumab injɛkshɔn? Lɛ wi tɔk bɔt dis mɛrɛsin insay simpul wɔd dɛn (Obinutuzumab injection) .

Dɛn dɔn gi yu di Obinutuzumab injɛkshɔn? Lɛ wi tɔk bɔt dis mɛrɛsin insay simpul wɔd dɛn (Obinutuzumab injection) .

Yu ɔ pɔsin we yu sabi go dɔn fil smɔl fred ɛn fred we yu dɔktɔ tɛl yu fɔ bigin tek Obinutuzumab. Yu kin gɛt bɔku kwɛstyɔn dɛn lɛk, ‘Wetin na dis mɛrɛsin? Wetin go apin wit dis?’ Dat na rili nɔmal tin. Kansa tritmɛnt na lɔng waka, ɛn fɔ ɔndastand klia wan di mɛrɛsin dɛm wae yu go de tek go ɛp yu bɔrku. So tide, lɛ wi tɔk bɔt dis mɛrɛsin, dis impɔtant pat pan yu tritmɛnt joyn, insay wan rili simpul ɛn padi we.

Mek wi si fos, wetin na Obinutuzumab?

Fɔ tɔk am simpul wan, Obinutuzumab na wan mɛrɛsin we rili advans fɔ fɛt kansa. I de pan wan spɛshal klas ɔf drɔgs we dɛn kɔl `monoclonal antibodies.` Tink bɔt am lɛk sojaman we gɛt bɔku sɛns, we tren. Di wangren tin we i want fɔ du na fɔ fɛn, atak, ɛn pwɛl di kansa sɛl dɛn na wi bɔdi. Dis drɔg gɛt di spɛshal pawa fɔ tɔch ɛn atak di kansa sɛl dɛn nɔmɔ, we de mek di sɛl dɛn we gɛt wɛlbɔdi nɔ pwɛl.

Dɛn kin yuz dis mɛrɛsin mɔ fɔ mɛn tu kayn kansa dɛn we gɛt fɔ du wit blɔd:

1. Chronic Lymphocytic Leukemia (CLL): Dis na kansa we de na di wayt blɔd sɛl dɛn.

2. Fɔlikul Limfoma: Dis na wan kayn kansa we de apin na di limfatik sistɛm. i de pan wan big grup fכ kεnsar dεm we dεn kכl `Non-Hodgkin Lymphoma (NHL).`

Sɔntɛnde yu dɔktɔ kin gi yu dis mɛrɛsin bak fɔ ɔda mɛrɛsin, so if yu gɛt ɛni kwɛstyɔn, nɔ fred fɔ tɔk to yu dɔktɔ bɔt am.

Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu bigin dis mɛrɛsin

Yu sef na di tin we impɔtant pas ɔl. So, i impɔtant fɔ mek yu tɛl yu dɔktɔ bɔt yu kɔmplit wɛlbɔdi istri bifo yu bigin dis tritmɛnt. Mek shɔ se yu tɛl dɛn bɔt ɛni wan pan dɛn tin ya, mɔ if yu gɛt ɛni wan pan dɛn tin ya:

  • Infεkshכn dεm naw: Tεl wi if yu gεt eni infεkshכn naw, lεk fiva, kכf, כ kol. Dis impɔtant mɔ if yu dɔn gɛt di epataytis B vayrɔs trade.
  • Lung ɔr respiratory disease: If yu gɛt prɔblɛm wit yu brith lɛk asma.
  • At sik: If yu bin dɔn gɛt at atak, yu at ritm prɔblɛm, ɔr ɛni ɔda at sik.
  • Di mɛrɛsin dɛn we dɛn kin yuz fɔ mek blɔd nɔ klɔt ɔ fɔ trit: If yu de tek tin dɛn we de mek blɔd tan lɛk Warfarin ɔ Aspirin.
  • Alɛji: If yu gɛt alɛji to dis mɛrɛsin, Obinutuzumab, ɔ ɛni ɔda mɛrɛsin, it, ɔ day.
  • Bɛlɛ: Dis rili impɔtant if yu gɛt bɛlɛ, yu de tray fɔ gɛt bɛlɛ, ɔ yu tink se yu gɛt bɛlɛ .
  • Fɔ gi pikin in bɛlɛ: If yu na mama we de gi pikin in bɛlɛ, yu fɔ rili tɔk bɔt dat bak.

Aw a go gi yu dis mɛrɛsin?

Dɛn kin gi dis mɛrɛsin as infushɔn insay wan vein. Dis nɔto sɔntin we yu go ebul fɔ du na os. Dɛn kin gi yu na ɔspitul ɔ klinik, ɔnda di sɔpɔtishɔn fɔ di dɔktɔ dɛn we tren . Di fɔs tɛm we dɛn gi yu di mɛrɛsin, dɛn go gi yu am smɔl smɔl. Dis na fɔ si aw yu bɔdi de ansa di mɛrɛsin. If ɔltin go fayn, yu kin gi am kwik kwik wan di nɛks tɛm.

Impɔtant: Dɛn dɔn gi yu dis mɛrɛsin fɔ yu nɔmɔ. Nɔ sheb am wit ɛni ɔda pɔsin fɔ ɛni rizin.

Wetin a go du if a mis wan doz fɔ tek mɛrɛsin?

I rili impɔtant fɔ kip di de dɛn we dɛn dɔn sɛtul fɔ dis tritmɛnt. If yu nɔ ebul fɔ go na ɔspitul di de we dɛn dɔn plan fɔ go, kɔl yu dɔktɔ ɔ klinik wantɛm wantɛm ɛn mek dɛn no. Dɛn go tɛl yu wetin fɔ du nɛks.

Wetin fɔ du if di mɛrɛsin go ɔp?

Bikɔs dɛn kin gi dis na ɔspitul, di chans fɔ mek dɛn tek am pasmak kin rili smɔl. Bɔt if yu tink se sɔntin lɛk dis kin apin, tɛl di dɔktɔ dɛn wantɛm wantɛm. Ɔda we de fɔ kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta na di Kɔlɔmbɔ Nashɔnal Ospital , ɔ go na di Imejɛnsi Tritmɛnt Yunit (ETU) na di ɔspitul we de nia yu.

Tin dɛm wae yu fɔ no bɔt wae yu de trit yu

I rili impɔtant fɔ pe atɛnshɔn to di chenj dɛn we de apin na yu bɔdi we yu de tek dis mɛrɛsin.

  • Riakshɔn afta di fɔs doz: We yu fɔs tek di mɛrɛsin, sɔm pipul dɛn kin gɛt fiva, kol, diziz, ɛn smɔl chenj na dɛn brith. Dɛn tin ya na nɔmal tin. Bɔt if yu gɛt ɛni wan pan dɛn tin ya, tɛl di nɔs ɔ dɔktɔ wantɛm wantɛm.
  • Protɛkt yusɛf frɔm infɛkshɔn: Dis mɛrɛsin kin mek yu bɔdi nɔ ebul fɔ fɛt sik (immunity). So, yu kin gɛt infɛkshɔn mɔ. Stay away frɔm pipul dɛm wae gɛt kol ɛn flu as mɔr as yu ebul. If yu gɛt sɔm sayn dɛn lɛk fiva, bɔdi we de at, trot we de at, ɛn kɔf, nɔ fɔ tek mɛrɛsin fɔ yusɛf ɛn kɔl yu dɔktɔ wantɛm wantɛm.
  • Risk fɔ blɔd: Dis mɛrɛsin kin mek yu blɔd ɔ brus smɔl smɔl. Tɛl yu dɔktɔ if yu gɛt ɛni ɔdinari brus, blɔd we de kɔmɔt na yu gɔm we yu de brus yu tit, ɔ ɛni ɔda blɔd we nɔ kɔmɔn.
  • Bεlε εn bεlε (i rili imכtant): Nɔ bεlε we yu de tek dis mεdisin εn fכ 6 mכnt afta yu stכp di tritmεnt. Dis mɛrɛsin kin ambɔg di pikin we nɔ bɔn yet bad bad wan. So, tɔk to yu dɔktɔ bɔt di bɛst we fɔ kɔntrol di pikin. Bak,Nɔ gi yu pikin in bɛlɛ we yu de trit am ɛn fɔ 6 mɔnt afta yu dɔn stɔp.

Wetin na di sayd ɛfɛkt dɛn we di mɛrɛsin kin gɛt?

Lɛk ɛni mɛrɛsin, Obinutuzumab kin mek yu gɛt sayd ɛfɛkt. Bɔt, nɔto ɔlman kin gɛt dɛn. Di tebul we de dɔŋ ya de sho klia wan bɔt dɛn tin ya.

Nature of di sayd ɛfɛkt Diskripshɔn ɛn di simptom dɛm
Sayd ɛfɛkt dɛn we yu fɔ ripɔt to yu dɔktɔ wantɛm wantɛm
Alɛji we pɔsin kin gɛt Skin rash, it, swel na di lip ɔ fes.
I nɔ izi fɔ blo I nɔ izi fɔ blo, di chɛst tayt ɔ pen.
Di sayn dɛn we de sho se di blɔd sɛl dɛn nɔ bɔku Dis mɛrɛsin kin mek di wayt blɔd sɛl dɛn, di rɛd blɔd sɛl dɛn, ɛn di pletlɛt dɛn nɔ bɔku. Dis kin mek di risk fɔ gɛt infɛkshɔn (fiva, kɔf), blɔd (bruiz, blak stɔl).
Di sayn dɛm we de sho se di liva dɔn pwɛl Dak yɔlɔ/brawn urine, yu yay ɔ skin de yɔlɔ, pen na di ɔp rayt pat na di bɛlɛ, taya pasmak, nɔs.
Simptom dɛm wae gɛt fɔ du wit di nervɔs sistɛm I nɔ kin tɔk fayn, i nɔ kin izi fɔ ɔndastand, i nɔ kin izi fɔ waka, i nɔ kin balans, i kin vɔmit, i kin gɛt siriɔs diziz.
Sayd ɛfɛkt dɛn we nɔ kin nid fɔ go to dɔktɔ (bɔt dɛn fɔ ripɔt to dɔktɔ if dɛn kɔntinyu fɔ du am) .
Ɔda smɔl smɔl sik dɛn Kɔnstipɛshɔn, jɔyn pen, mɔsul pen.

Dis list nɔ de inklud ɔl di sayd ɛfɛkt dɛn we pɔsin kin gɛt. If yu notis ɛni ɔda tin we difrɛn ɔ we nɔ kɔmɔn, duya tɛl yu dɔktɔ.

Mɛsej we dɛn kin kɛr go na os

  • Obinutuzumab na wan advans drɔg we de tɔch ɛn pwɛl kansa sɛl dɛn. Dis na impɔtant pat pan yu tritmɛnt joyn.
  • Bifo yu bigin fɔ trit yu, tɛl yu dɔktɔ bɔt ɔl yu wɛlbɔdi prɔblɛm ɛn di mɛrɛsin dɛn we yu de tek.
  • Protɛkt yusɛf frɔm infɛkshɔn we yu de du tritmɛnt. If yu gɛt sɔm sayn dɛn lɛk fiva ɛn kɔf, go to dɔktɔ wantɛm wantɛm.
  • I rili impɔtant: Nɔ gɛt bɛlɛ ɔltogɛda we yu de trit yu ɛn fɔ 6 mɔnt afta yu dɔn stɔp.
  • Nɔ skip di apɔntinmɛnt dɛn we yu dɔn plan fɔ tek fɔ tek mɛrɛsin. If yu gɛt ɛni prɔblɛm, tɛl di ɔspitul bifo tɛm.
  • Tɛl yu dɔktɔ wantɛm wantɛm bɔt ɛni chenj we nɔ kɔmɔn na yu bɔdi, mɔ di sayn dɛn we de sho se yu gɛt siriɔs sayd ɛfɛkt. Nɔ fred ɔ sɔfa yu wan. Di mɛdikal tim de ya fɔ ɛp yu.

obinutuzumab, gazyva, kansa tritmɛnt, monoklɔnal antibodi, kronik limfosaytik lukimiya, fɔlikul limfoma, kansa mɛrɛsin
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 2 + 7 =